Elisabeth Zambelis
Elisabeth Zambelis invests in deep-tech ventures and startups with immediate market viability, focusing on health (including femtech & sextech), fintech, and climate sectors. She leverages her experience as a health startup co-founder and a 10-year background in corporate finance to guide startups with both capital and insights.
About Elisabeth Zambelis
Elisabeth Zambelis appears in the source data as an individual angel investor with a LinkedIn profile but no website, Crunchbase, or disclosed thesis, stage, sector, or check size. This is a thin profile typical of operator-angels investing small checks based on personal network and area expertise rather than a formalized investment thesis. For healthcare AI founders, the realistic expectation is a small angel check, likely $5K to $50K, with no confirmed healthcare specialization. The probability that Zambelis is a thesis-aligned healthcare AI investor cannot be determined without specific evidence in her LinkedIn background. The most plausible value, if any, is operational or domain advice rather than meaningful capital, particularly if her professional background overlaps with relevant areas like consumer health, healthcare operations, women’s health, or AI. Founders should pre-qualify by reviewing her LinkedIn profile for current role, prior experience, and any healthcare or AI signals before significant outreach. Entry path is direct LinkedIn outreach with a short, specific note asking about check capacity, recent investments, and interest areas. If her background is in adjacent or unrelated categories, founder time is better spent on disclosed-thesis healthcare angels and small funds. Be candid about expectations: at this footprint, even a positive response is unlikely to produce a meaningful portion of a round, and the effort-to-yield ratio favors prioritizing investors with established healthcare track records. Treat Zambelis as a low-priority outreach during angel round assembly, with a brief introductory message rather than a full pitch deck cycle. Founder fundraising time is finite; allocate it to higher-signal targets first.
Founder reviews
Other portfolio companies
Companies in Elisabeth Zambelis's portfolio not currently in our directory.
- Aetion · 2017
- Tempus · 2017
- Pear Therapeutics · 2017
- Mindstrong Health · 2017
- Evidation Health · 2017
- Freenome · 2017
- Color Genomics · 2017
- Verily Life Sciences · 2017
- GRAIL · 2017
- Flatiron Health · 2017
Team
Pitch / review this investor
Have you raised from Elisabeth Zambelis? Founders only — share your honest experience (anonymous OK, moderated before publishing).